T1	Participants 153 209	advanced laryngeal and hypopharyngeal squamous carcinoma
T2	Participants 212 326	Two hundred and twelve patients with previously untreated advanced squamous carcinoma of the larynx or hypopharynx
T3	Participants 767 848	Two hundred and nine of the 212 patients randomized were included in the analyses
